NCT06321198View on ClinicalTrials.gov

A Trial to Evaluate the Safety and Preliminary Efficacy of iMesenchymal Stromal Cells(iMSC) in Subjects With SR-aGVHD

NARecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 10, 2024

Primary Completion Date

March 2, 2027

Study Completion Date

March 2, 2027

Conditions
Steroid-refractory Acute Graft-versus-host Disease(SR-aGVHD)
Interventions
BIOLOGICAL

iMSC

Subjects will receive 4 or more times of iMSC injection

Trial Locations (1)

230036

RECRUITING

Anhui Provincial Hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV